Cephalothin Sodium

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Dec 18, 1974	KeflinNDA 50482 · New dosage form	Lilly	22	Discontinued
Jan 31, 1984	Cephalothin Sodium W/ Sodium Chloride In Plastic Container, Cephalothin Sodium W/ Dextrose In Plastic ContainerANDA 62422	Baxter Hlthcare	1	Discontinued
Sep 10, 1985	Keflin In Plastic ContainerANDA 62549	Lilly	1	Discontinued
Mar 5, 1987	Cephalothin Sodium W/ Dextrose In Plastic ContainerANDA 62730	Baxter Hlthcare	2	Discontinued
—	CephalothinANDA 62426	Intl Medication	0	Discontinued
—	SeffinANDA 62435	Glaxosmithkline	0	Discontinued
—	Cephalothin SodiumANDA 62464	Bristol	0	Discontinued
—	Cephalothin SodiumANDA 62547	Abbott	0	Discontinued
—	Cephalothin SodiumANDA 62548	Abbott	0	Discontinued
—	Cephalothin SodiumANDA 62666	Abraxis Pharm	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA